Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5
The effect of Aramchol on fibrosis is mediated by downregulation of steatosis and directly on human collagen producing cells.
- The effect of Aramchol on fibrosis is mediated by downregulation of steatosis and directly on human collagen producing cells.
- Aramchol has been granted Fast Track designation status by the FDA for the treatment of NASH.
- NASH is the progressive form of non-alcoholic fatty liver disease that can lead to cardiovascular disease, cirrhosis and liver-related mortality.
- Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases.